A Review of Hypertensive Disorders Management During Pregnancy

Background: hypertensive disorders are the second direct cause of maternal deathaffecting 5 – 10 % of pregnancies. these disorders are associated with increased risk ofintracerebral hemorrhage, placental abruption, intrauterine growth retardation, prematurity,and intrauterine death. chronic hypertension, gestational hypertension, pre-eclampsia,eclampsia, chronic hypertension with superimposed pre-eclampsia are hypertensivedisorders in pregnancy.methods: narriative review.results: hypertension control measurement for these conditions includes complete bloodcount (cbc), serum creatinine (scr), liver enzymes and 24-h urine protein. ultrasonographicevaluation of fetus and nonstress test also should be considered. oral pharmacologicinterventions for chronic hypertensin during pregnancy includes methyldopa, labetalol andnifedipine. the use of angiotensin-converting enzyme inhibitors (ace-i) and angiotensin-iireceptor antagonists could not be used due to teratogenicity. pre-eclampsia is a disorderwhich worsens when the pregnancy continues, so the definitive treatment of pre-eclampsiais delivery. the indication for delivery in women with gestational hypertension or preeclampsiaincludes gestational age ≥ 27 weeks, uncontrollable hypertension, persistentneurological symptoms or eclampsia, deteriorating liver and renal function, placentalabruption, acute pulmonary edema, persistent epigastric pain with nausea or vomiting withabnormal liver function tests and severe fgr.conclusion: hypertensive disorders in pregnancy could increase the risk fetal and maternalmortality. therefore, early detection and proper management of hypertension needs to bedone in pregnant women.